PortfoliosLab logoPortfoliosLab logo
UFPT vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UFPT vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UFPT achieves a 5.61% return, which is significantly higher than ABBV's 4.43% return. Over the past 10 years, UFPT has outperformed ABBV with an annualized return of 27.27%, while ABBV has yielded a comparatively lower 19.47% annualized return.


UFPT

1D
0.51%
1M
2.41%
YTD
5.61%
6M
0.78%
1Y
0.57%
3Y*
7.05%
5Y*
31.78%
10Y*
27.27%

ABBV

1D
2.07%
1M
8.84%
YTD
4.43%
6M
4.29%
1Y
31.92%
3Y*
24.36%
5Y*
19.80%
10Y*
19.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UFPT vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UFPT
UFP Technologies, Inc.
5.61%-9.19%42.12%45.93%67.79%50.77%-6.07%65.15%8.06%9.23%
ABBV
AbbVie Inc.
4.43%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between UFPT and ABBV is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.16

Fundamentals

Market Cap

UFPT:

$1.83B

ABBV:

$416.46B

EPS

UFPT:

$8.81

ABBV:

$2.05

PE Ratio

UFPT:

26.61

ABBV:

114.38

PS Ratio

UFPT:

3.00

ABBV:

6.63

PB Ratio

UFPT:

4.17

ABBV:

15.14

Total Revenue (TTM)

UFPT:

$608.85M

ABBV:

$62.82B

Gross Profit (TTM)

UFPT:

$172.62M

ABBV:

$46.15B

EBITDA (TTM)

UFPT:

$111.39M

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UFPT vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UFPT
UFPT Risk / Return Rank: 4141
Overall Rank
UFPT Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
UFPT Sortino Ratio Rank: 4040
Sortino Ratio Rank
UFPT Omega Ratio Rank: 3939
Omega Ratio Rank
UFPT Calmar Ratio Rank: 4343
Calmar Ratio Rank
UFPT Martin Ratio Rank: 4242
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 7575
Overall Rank
ABBV Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 7575
Sortino Ratio Rank
ABBV Omega Ratio Rank: 7373
Omega Ratio Rank
ABBV Calmar Ratio Rank: 7474
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UFPT vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


UFPTABBVDifference
Sharpe ratioReturn per unit of total volatility

-1.26

Sortino ratioReturn per unit of downside risk

-1.56

Omega ratioGain probability vs. loss probability

1.04

1.24

-0.19

Calmar ratioReturn relative to maximum drawdown

0.02

1.85

-1.83

Martin ratioReturn relative to average drawdown

0.03

4.11

-4.08

UFPT vs. ABBV - Sharpe Ratio Comparison

The current UFPT Sharpe Ratio is 0.01, which is lower than the ABBV Sharpe Ratio of 1.27. The chart below compares the historical Sharpe Ratios of UFPT and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

UFPT vs. ABBV - Drawdown Comparison

The maximum UFPT drawdown since its inception was -88.53%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for UFPT and ABBV.


Loading charts...

Drawdown Indicators


UFPTABBVDifference

Max Drawdown

Largest peak-to-trough decline

-88.53%

-45.09%

-43.44%

Max Drawdown (1Y)

Largest decline over 1 year

-30.69%

-17.32%

-13.37%

Max Drawdown (3Y)

Largest decline over 3 years

-48.31%

-20.74%

-27.57%

Max Drawdown (5Y)

Largest decline over 5 years

-48.31%

-21.92%

-26.39%

Max Drawdown (10Y)

Largest decline over 10 years

-48.31%

-45.09%

-3.22%

Current Drawdown

Current decline from peak

-34.58%

-1.66%

-32.92%

Average Drawdown

Average peak-to-trough decline

-32.24%

-10.70%

-21.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.96%

7.78%

+9.18%

Volatility

UFPT vs. ABBV - Volatility Comparison

UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV) have volatilities of 8.94% and 9.26%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UFPTABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.94%

9.26%

-0.32%

Volatility (6M)

Calculated over the trailing 6-month period

30.66%

19.11%

+11.55%

Volatility (1Y)

Calculated over the trailing 1-year period

43.71%

25.23%

+18.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.31%

23.12%

+21.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.57%

25.83%

+13.74%

Dividends

UFPT vs. ABBV - Dividend Comparison

UFPT has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 2.87%.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.87%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
UFPT
UFP Technologies, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

UFPT vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between UFP Technologies, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
154.20M
15.00B
(UFPT) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

UFPT vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between UFP Technologies, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
28.8%
83.5%
Portfolio components
UFPT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported a gross profit of 44.36M and revenue of 154.20M. Therefore, the gross margin over that period was 28.8%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

UFPT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported an operating income of 23.37M and revenue of 154.20M, resulting in an operating margin of 15.2%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

UFPT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported a net income of 17.50M and revenue of 154.20M, resulting in a net margin of 11.4%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


UFPT and ABBV have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (9.26%) compared to UFPT (8.94%). In terms of maximum drawdown, UFPT dropped -88.53% vs ABBV's -45.09%.

ABBV currently has the higher Sharpe Ratio (1.27 vs 0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UFPT and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer